Article Text

Download PDFPDF

Correction: Efficacy and safety of avelumab treatment in patients with metastatic Merkel cell carcinoma: experience from a global expanded access program

Statistics from Altmetric.com

Walker JW, Lebbé C, Grignani G, et al. Efficacy and safety of avelumab treatment in patients with metastatic Merkel cell carcinoma: experience from a global expanded access program. J Immunother Cancer 2020;8:e000313. doi: 10.1136/jitc-2019-000313.

Since the online publication of this article, the authors have noticed errors in Table 1 and 2. In Table 1, the header 'Approved immunocompromised patients (n=33)' should read 'Approved immunocompromised patients (n=37)' as the total number of patients is 37. Additionally in Table 2 row ‘CR’, column ‘1L (n=15)’, the data value is incorrectly stated as ‘5 (33.3)2 (13.3)’. The correct data value is ‘2 (13.3)’.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.